For the non-endoscopic treatment of female Stress Urinary Incontinence under local anaesthetic, incorporating the revolutionary Macroplastique Implantation Device (MID) for accurate and symmetrical product placement and delivery of Macroplastique material in the female urethra.
The uniquely designed Macroplastique Implantation System combines the proven performance of Macroplastique implants with a unique non-endoscopic delivery method.
Simple Procedure
- Using the Macroplastique Insertion Device (MID) to position the needle in tissue, Macroplastique is injected at predefined sites and depths in the female urethra.
Lower Risk, Less Anxiety
- Outpatient procedure with local anaesthetic.
- Lower risk of complications than more invasive procedures.
- Less risk means less anxiety for patients making it a more attractive option.
More Satisfied Patients
- Recent data suggests that the majority of woman prefer clinic procedures such as non-endoscopic urethral bulking with the MIS.*
- For many patients, a lower rate of complications may be a higher priority than the outright published success rate alone.*
More Information
* Robinson, D., Anders, K., Cardozo, L., Bidmead, J., Dixon, A., Balmforth, J., et al. (2002) What women want – their interpretation of the concept of cure. Neurol Urol Urodyn, 21, 429-430.
